10-QPeriod: Q3 FY1999

QUEST DIAGNOSTICS INC Quarterly Report for Q3 Ended Sep 30, 1999

Filed November 15, 1999For Securities:DGX

Summary

Quest Diagnostics Inc. (DGX) filed its 10-Q quarterly report for the period ending September 30, 1999, on November 15, 1999. This filing provides a snapshot of the company's financial performance and position during the third quarter of 1999. Investors can gain insights into the company's operational efficiency and financial health as it navigated the competitive diagnostic testing landscape at the turn of the millennium. While specific financial figures are not detailed in the provided text, the filing itself signifies Quest Diagnostics' commitment to regulatory transparency. Investors would typically examine this report for key metrics such as revenue growth, profitability, changes in assets and liabilities, and any significant business developments or risks disclosed by management. The period was characterized by increasing demand for healthcare services, and Quest Diagnostics, as a major player, would be expected to demonstrate its ability to capitalize on these trends.

Key Highlights

  • 1Filed 10-Q quarterly report for the period ending September 30, 1999.
  • 2Report was filed on November 15, 1999, providing a timely update for investors.
  • 3Quest Diagnostics Inc. (DGX) is the reporting entity.
  • 4The filing offers insights into the company's financial performance during the third quarter of 1999.
  • 5Investors can assess operational efficiency and financial health based on the full report.
  • 6The report adheres to SEC filing requirements, demonstrating transparency.
  • 7This filing reflects the business environment of the healthcare and diagnostic testing industry at the close of the 20th century.

Frequently Asked Questions

The primary purpose of this 10-Q filing is to provide investors and the public with a comprehensive update on Quest Diagnostics Inc.'s financial performance and position for the third quarter of 1999. It includes unaudited financial statements and management's discussion and analysis of financial condition and results of operations.

While the provided text is a directory listing, a full 10-Q report typically contains detailed financial statements, including the balance sheet, income statement, and cash flow statement. Investors can also find information on revenue, expenses, profitability, assets, liabilities, equity, and important disclosures regarding the company's business and risks.

The filing date of November 15, 1999, indicates that Quest Diagnostics submitted its quarterly report to the SEC within the mandated timeframe following the close of its fiscal third quarter on September 30, 1999. This suggests a commitment to timely financial reporting.

By analyzing the financial results and management's commentary within the full 10-Q report, investors can gauge Quest Diagnostics' revenue growth, profitability trends, and operational efficiency compared to its peers in the diagnostic testing industry during the late 1990s. It provides a basis for assessing the company's competitive standing and growth prospects at that time.